Moderna Inc (NASDAQ:MRNA)

142.85
Delayed Data
As of Jun 30
 +0.04 / +0.03%
Today’s Change
115.61
Today|||52-Week Range
497.49
-43.76%
Year-to-Date
Could This Send Moderna's Stock Soaring Back to $400?
Jun 30 / MotleyFool.com - Paid Partner Content
FDA Panel Recommends Modifying COVID Jabs to Target Omicron
Jun 29 / Zacks.com - Paid Partner Content
Is Pfizer Stock a Buy Now?
Jun 30 / MotleyFool.com - Paid Partner Content
2 Dividend Stocks With Huge Passive Income Potential
Jun 29 / MotleyFool.com - Paid Partner Content
3 Things About Moderna That Smart Investors Know
Jun 30 / MotleyFool.com - Paid Partner Content
The 3 Smartest Real Estate Stocks to Buy Right Now
Jun 28 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Inks Deal With US Government for COVID Jab Supply
Jun 30 / Zacks.com - Paid Partner Content
Moderna (MRNA) Gains As Market Dips: What You Should Know
Jun 27 / Zacks.com - Paid Partner Content
The Chef's Warehouse and AZEK have been highlighted as Zacks Bull and Bear of the Day
Jun 30 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Omicron-Based COVID Shot Betters Immune Response
Jun 27 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close142.81
Today’s open143.32
Day’s range135.57 - 147.30
Volume185,610
Average volume (3 months)6,676,451
Market cap$57.4B
Data as of 4:02pm ET, 06/30/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1.10%
Earnings growth (next 5 years)-37.57%
Revenue growth (last year)+2,191.90%
P/E ratio4.2
Price/Sales5.95
Price/Book4.11

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.66-1.06%
BIIBBiogen-1.19-0.58%
ILMNIllumina Inc-2.07-1.11%
----
Data as of 4:02pm ET, 06/30/2022

Financials

Next reporting dateAugust 3, 2022
EPS forecast (this quarter)$4.75
Annual revenue (last year)$18.4B
Annual profit (last year)$12.2B
Net profit margin66.27%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts